RAPIDE: The Feasibility of a Hybrid Care Model

Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Dec 11, 2024

Keywords

ClinConnect Summary

The RAPIDE trial is exploring a new way to provide care for patients with type 2 diabetes and heart failure, especially during times when healthcare systems are stretched, like during a pandemic. This approach combines traditional in-person care with digital tools, allowing patients to monitor their health from home and communicate with their doctors remotely. The goal is to see if this "hybrid care model" can improve patient experiences and health outcomes while easing the burden on healthcare facilities.

To be eligible for this study, participants must have type 2 diabetes or chronic heart failure along with at least two other chronic health issues. They should also have had many medical appointments or hospital referrals in the past two years. Those involved can expect to take part in home visits, answer questionnaires, and share their experiences through interviews over the course of a year. Importantly, this study does not involve any invasive procedures, making it a low-risk option for eligible patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• In order to be eligible to participate in this study, a subject must meet all of the following criteria:
• Patients with type 2 diabetes mellitus, WITH:
• • At least 2 different types of chronic comorbidities (as defined in the list of chronic comorbidities); AND
• • A high number of medical consultations at the GP practice and/or referrals to the hospital in the last 24 months, as identified by the clinical expertise of the treating GP.
• Patients with chronic heart failure, WITH:
• • At least 2 different types of chronic comorbidities (as defined in the list of chronic comorbidities); AND
• • A high number of medical consultations at the GP practice and/or referrals to the hospital in the last 24 months, as identified by the clinical expertise of the treating GP.
• Exclusion Criteria:
• • Terminally ill patients
• • Comorbidity of a severe psychiatric disorder (i.e. psychosis-related disorders, dementia, and bipolar disorder)
• • Patients who are cognitively impaired